comprehensive -WSS

comprehensive

author：entertainment 2025-09-05 11:26:01 - browse：38

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： Heat waves linked to early deliveries, preterm births in new study

leisure time

WSS

NYC plans to house migrants on an island in the East River

Childbirth

Health insurers say they are turning to AI to cut costs, improve care

Focused ultrasound for uterine fibroids: an uphill battle

Latest bird flu infection made farmworker sicker than earlier cases

Do more moles mean more problems? Not so, says new study

Wikipedia

comprehensive

hotspot

Medicare details structure of new drug price negotiation program

Health insurers say they are turning to AI to cut costs, improve care

Medical leaders decry Supreme Court decision on affirmative action

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

iTeos Therapeutics debuts first data on TIGIT

Jerome Adams on the need for new antivirals for Covid

Democratic lawmaker calls for 'well

hotspot

Report: NIH

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Do more moles mean more problems? Not so, says new study

Insmed lung disease drug hits target in key Phase 3 trial

Why workplace violence is so common in health care

Trump Jan. 6 attorney John Lauro is ex

entertainment

explore

leisure time

knowledge